STOCK TITAN
  1. Home
  2. Sec-filings
  3. STAA
  4. [Form 4] STAAR SURGICAL CO Insider Trading Activity

STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STAAR Surgical director Richard T. LeBuhn received a new stock option grant as part of his director compensation. He was granted options covering 11,145 shares of common stock at an exercise price of $29.12 per share, with no cash paid for the grant.

These options will vest and become exercisable on the earlier of June 18, 2027 or the company’s next annual shareholder meeting after the grant date, subject to his continuous service. LeBuhn also holds previously granted options covering 7,524 shares at an exercise price of $18.46 per share that are currently exercisable and expire in 2036.

Positive

  • None.

Negative

  • None.
Insider LeBuhn Richard T.
Role null
Type Security Shares Price Value
Grant/Award OPTION TO PURCHASE COMMON STOCK 11,145 $0.00 --
holding OPTION TO PURCHASE COMMON STOCK -- -- --
Holdings After Transaction: OPTION TO PURCHASE COMMON STOCK — 11,145 shares (Direct, null)
Footnotes (1)
  1. These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer. These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended. These options are currently exercisable.
New option grant size 11,145 options Director grant on June 18, 2026
New option exercise price $29.12 per share Grant to Richard T. LeBuhn
New option expiration June 18, 2036 Option term for 11,145-share grant
Existing options underlying shares 7,524 shares Previously granted, currently exercisable
Existing options exercise price $18.46 per share Earlier grant exercisable to 2036
Existing options expiration March 5, 2036 Option to purchase common stock
Amended and Restated Omnibus Equity Incentive Plan financial
"These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended."
director compensation financial
"These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended."
vest and become exercisable financial
"These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's next annual meeting of shareholders after the grant date."
continuous service financial
"subject, in each case, to Richard T. LeBuhn's continuous service with the Issuer."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LeBuhn Richard T.
(Last)(First)(Middle)
C/O BROADWOOD CAPITAL, INC.
156 WEST 56TH STREET, 3RD FLOOR
(Street)
NEW YORK NEW YORK 10019
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
OPTION TO PURCHASE COMMON STOCK$29.1206/18/2026A11,145 (1)06/18/2036COMMON STOCK11,145$0(2)11,145D
OPTION TO PURCHASE COMMON STOCK$18.46 (3)03/05/2036COMMON STOCK7,5247,524D
Explanation of Responses:
1. These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer.
2. These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.
3. These options are currently exercisable.
/s/ Richard T. LeBuhn06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did STAAR Surgical (STAA) director Richard T. LeBuhn receive in this filing?

Richard T. LeBuhn received a grant of stock options covering 11,145 shares of STAAR Surgical common stock. The grant is part of his director compensation and allows him to buy shares at a fixed exercise price of $29.12 per share once the options vest.

When do Richard T. LeBuhn’s newly granted STAAR Surgical (STAA) options vest?

The new options vest on the earlier of June 18, 2027 or the date of STAAR Surgical’s next annual shareholder meeting after the June 18, 2026 grant. Vesting requires LeBuhn’s continuous service as a director with the company until that vesting date.

What is the exercise price and expiration date of the new STAAR Surgical (STAA) options?

The new options have an exercise price of $29.12 per share and expire on June 18, 2036. This means LeBuhn may purchase STAAR Surgical common stock at $29.12 per share any time after vesting and before the options expire, subject to plan terms.

Does Richard T. LeBuhn already hold other STAAR Surgical (STAA) stock options?

Yes. He holds previously granted options covering 7,524 shares of STAAR Surgical common stock at an $18.46 exercise price. According to the disclosure, these earlier options are currently exercisable and are scheduled to expire in March 2036 if not exercised.

How were the new STAAR Surgical (STAA) options to Richard T. LeBuhn issued?

The options were granted on June 18, 2026 as director compensation under STAAR Surgical’s Amended and Restated Omnibus Equity Incentive Plan. The grant involves no purchase price at grant; value arises only if the share price exceeds the $29.12 exercise price.